Liling Huang

3PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 17, 2026
Comparative efficacy and safety of systemic therapies in transplant-eligible and ineligible relapsed/refractory large B-cell lymphoma: a Bayesian network meta-analysis.

|Jan 23, 2023
Analysis on methylation and expression of PSMB8 and its correlation with immunity and immunotherapy in lung adenocarcinoma.

Tongji Xie, Guangyu Fan, Liling Huang

|Nov 01, 2022
DLX2 Is a Potential Immune-Related Prognostic Indicator Associated with Remodeling of Tumor Microenvironment in Lung Squamous Cell Carcinoma: An Integrated Bioinformatical Analysis.

Liling Huang, Tongji Xie, Fuqiang Zhao

Pageof 1

Frequent Collaborators

2 joint publications

Tongji Xie

2 joint publications

Xiaohong Han

2 joint publications

Yuankai Shi

1 joint publications

Fuqiang Zhao